103 related articles for article (PubMed ID: 34461126)
1. Advances of natural activators for Nrf2 signaling pathway on cholestatic liver injury protection: a review.
He L; Guo C; Peng C; Li Y
Eur J Pharmacol; 2021 Nov; 910():174447. PubMed ID: 34461126
[TBL] [Abstract][Full Text] [Related]
2. Artemisia capillaris Thunb. Polysaccharide alleviates cholestatic liver injury through gut microbiota modulation and Nrf2 signaling pathway activation in mice.
Cai J; Zhu Z; Li Y; Li Q; Tian T; Meng Q; Wang T; Ma Y; Wu J
J Ethnopharmacol; 2024 Jun; 327():118009. PubMed ID: 38447617
[TBL] [Abstract][Full Text] [Related]
3. Potential Targets of Natural Products for Improving Cardiac Ischemic Injury: The Role of Nrf2 Signaling Transduction.
Wang H; Han J; Dmitrii G; Zhang XA
Molecules; 2024 Apr; 29(9):. PubMed ID: 38731496
[TBL] [Abstract][Full Text] [Related]
4. Phytochemicals protect L02 cells against hepatotoxicity induced by emodin
Yan Y; Wang K; Tang X; Gao JF; Wen BY
Toxicol Res (Camb); 2019 Nov; 8(6):1028-1034. PubMed ID: 32153769
[TBL] [Abstract][Full Text] [Related]
5. Natural Products as Dietary Agents for the Prevention and Mitigation of Oxidative Damage and Inflammation in the Intestinal Barrier.
Martins-Gomes C; Nunes FM; Silva AM
Antioxidants (Basel); 2024 Jan; 13(1):. PubMed ID: 38247489
[TBL] [Abstract][Full Text] [Related]
6. Letter: Prioritising osteosarcopenia assessment in the ongoing care of patients with cholestatic liver diseases.
Arcari I; Colapietro F; Pugliese N
Aliment Pharmacol Ther; 2024 Feb; 59(4):583-584. PubMed ID: 38247144
[No Abstract] [Full Text] [Related]
7. Comments on: Unveiling the therapeutic promise of natural products in alleviating drug-induced liver injury: Present advancements and future prospects.
Jaeschke H; Ramachandran A
Phytother Res; 2024 Apr; 38(4):1781-1782. PubMed ID: 38317477
[No Abstract] [Full Text] [Related]
8. Reply: How does bile acid-induced IRF3 phosphorylation mediate cholestatic liver and kidney injury?-More needs to be known.
Zhuang Y; Szabo G
Hepatology; 2024 Jul; 80(1):E2-E3. PubMed ID: 38442007
[No Abstract] [Full Text] [Related]
9. The activation of nuclear factor-E2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) signaling blunts cholestasis-induced liver and kidney injury.
Mousavi K; Niknahad H; Li H; Jia Z; Manthari RK; Zhao Y; Shi X; Chen Y; Ahmadi A; Azarpira N; Khalvati B; Ommati MM; Heidari R
Toxicol Res (Camb); 2021 Aug; 10(4):911-927. PubMed ID: 34484683
[TBL] [Abstract][Full Text] [Related]
10. Geniposide Ameliorates Liver Fibrosis Through Reducing Oxidative Stress and Inflammatory Respose, Inhibiting Apoptosis and Modulating Overall Metabolism.
Yang L; Bi L; Jin L; Wang Y; Li Y; Li Z; He W; Cui H; Miao J; Wang L
Front Pharmacol; 2021; 12():772635. PubMed ID: 34899328
[TBL] [Abstract][Full Text] [Related]
11. Interplays of liver fibrosis-associated microRNAs: Molecular mechanisms and implications in diagnosis and therapy.
Li H; Liu T; Yang Y; Cho WC; Flynn RJ; Harandi MF; Song H; Luo X; Zheng Y
Genes Dis; 2023 Jul; 10(4):1457-1469. PubMed ID: 37397560
[TBL] [Abstract][Full Text] [Related]
12. Maresin-1 Prevents Liver Fibrosis by Targeting Nrf2 and NF-κB, Reducing Oxidative Stress and Inflammation.
Rodríguez MJ; Sabaj M; Tolosa G; Herrera Vielma F; Zúñiga MJ; González DR; Zúñiga-Hernández J
Cells; 2021 Dec; 10(12):. PubMed ID: 34943914
[TBL] [Abstract][Full Text] [Related]
13. Oxidative Stress Induced by Reactive Oxygen Species (ROS) and NADPH Oxidase 4 (NOX4) in the Pathogenesis of the Fibrotic Process in Systemic Sclerosis: A Promising Therapeutic Target.
Piera-Velazquez S; Jimenez SA
J Clin Med; 2021 Oct; 10(20):. PubMed ID: 34682914
[TBL] [Abstract][Full Text] [Related]
14. An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases.
Zgorzynska E; Dziedzic B; Walczewska A
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502501
[TBL] [Abstract][Full Text] [Related]
15. Targeting Nrf2/Keap1 signaling pathway by bioactive natural agents: Possible therapeutic strategy to combat liver disease.
Jayasuriya R; Dhamodharan U; Ali D; Ganesan K; Xu B; Ramkumar KM
Phytomedicine; 2021 Nov; 92():153755. PubMed ID: 34583226
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of NLRP3 inflammasome-mediated hepatic stellate cell activation: Therapeutic potential for liver fibrosis.
Charan HV; Dwivedi DK; Khan S; Jena G
Genes Dis; 2023 Mar; 10(2):480-494. PubMed ID: 37223529
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of peach kernel and safflower herb-pair for the treatment of liver fibrosis based on network pharmacology and molecular docking technology: A review.
Huang L; Yu Q; Peng H; Zhen Z
Medicine (Baltimore); 2023 Apr; 102(16):e33593. PubMed ID: 37083803
[TBL] [Abstract][Full Text] [Related]
18. Aspartate Reduces Liver Inflammation and Fibrosis by Suppressing the NLRP3 Inflammasome Pathway via Upregulating NS3TP1 Expression.
Zhou L; Zhao J; Han M; Ma A; Yang S; Zeng Y; Cheng J
J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983568
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant and Anti-Inflammatory Properties of Phytochemicals Found in the
Culhuac EB; Maggiolino A; Elghandour MMMY; De Palo P; Salem AZM
Antioxidants (Basel); 2023 Feb; 12(3):. PubMed ID: 36978823
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological Features of 18β-Glycyrrhetinic Acid: A Pentacyclic Triterpenoid of Therapeutic Potential.
Shinu P; Gupta GL; Sharma M; Khan S; Goyal M; Nair AB; Kumar M; Soliman WE; Rahman A; Attimarad M; Venugopala KN; Altaweel AAA
Plants (Basel); 2023 Mar; 12(5):. PubMed ID: 36903944
[No Abstract] [Full Text] [Related]
[Next] [New Search]
